Novo Nordisk
NVO

Novo Nordisk (NVO) news

Recent news

The companies will agree to provide discounts on outpatient drugs to state Medicaid programs - Bloomberg news

Pharmaceutical companies have agreed to provide significant discounts on outpatient drugs to state Medicaid programs, according to recent developments. These agreements are part of broader efforts to reduce prescription drug costs for Medicaid beneficiaries and align with federal initiatives aimed…

AInvest Wire · 5d ago

Lexicon Pharmaceuticals earns third $10 million milestone payment from Novo Nordisk following achievement of key Phase 1 development milestone for LX9851

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) has received a third $10 million milestone payment from Novo Nordisk A/S following the achievement of a key development milestone in the Phase 1 clinical trial of LX9851, a first-in-class oral non-incretin candidate for the treatment of obesity and…

AInvest Wire · 7d ago

European companies expected to report 24.1% increase in Q2 earnings vs 23.4% increase seen a week ago - LSEG IBES data

European companies are now expected to report a 24.1% increase in second-quarter earnings , up from a 23.4% increase estimated a week ago, according to LSEG IBES data. This upward revision reflects continued strong performance, particularly in the energy sector, where profits are projected to more…

AInvest Wire · Aug 19, 2026

Lilly escalates fight against black market weight-loss shots

Eli Lilly has intensified its efforts to combat the growing black market for weight-loss drugs, particularly those in the GLP-1 class such as Mounjaro and Zepbound. The surge in demand for these medications has led to an increase in counterfeit and illegally diverted products, posing significant…

AInvest Wire · Aug 12, 2026

Novo Nordisk: Berenberg cuts to hold from buy

AInvest Wire · Aug 12, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.